Human Papillomavirus (HPV), High Risk with 16 and 18 Genotype by PCR, ThinPrep
Also known as: TP HPV1618
Use
This test is used for the detection of high-risk HPV DNA including types 16 and 18 which are associated with cervical cancer. It is FDA-approved for routine cervical cancer screening in combination with cytology in individuals 30 years or older. It is also used as a follow-up for abnormal cytology in individuals 21 years or older.
Special Instructions
Not provided.
Limitations
This test does not rule out infection with other high-risk HPV types, future cytologic abnormalities, or underlying cervical neoplasia and cancer. It should not be used for screening atypical squamous cells of undetermined significance in women under age 21.
FDA ApprovedNew York Approved
Methodology
PCR-based (qPCR)
Biomarkers
LOINC Codes
- 31208-2
- 77399-4
- 82675-0
- 77400-0
Result Turnaround Time
1-5 days
Related Documents
For more information, please review the documents below
Specimen
Cervical Swab
Volume
Not provided
Minimum Volume
Not provided
Container
ThinPrep collection kit
Collection Instructions
Swirl the collection device vigorously in the PreservCyt Media.
Causes for Rejection
Bloody or dark brown specimens. Dry swab or specimens in any media other than ThinPrep Preservecyt.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 6 months |
| Refrigerated | 6 months |
| Frozen | Unacceptable |
Other tests from different labs that may be relevant